• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

FDA, NIH Respond to Charges of Lax Oversight

Article

The FDA and the National Institutes of Health don't agree with allegations that sponsors of clinical trials are not adhering to a federal law that requires public reporting of clinical trial data within one year of completion.

Both agencies wrote letters to Congress disputing charges leveled against them in an analysis published in January in BMJ that found that neither government-funded nor privately-funded studies for pre-approved drugs were being reported in a timely manner, according to an article published online this week in Nature.

Read the full story: http://hcp.lv/IPjReJ

Source: MedPage Today

Related Videos
4 experts in this video
4 experts in this video
Rakendu Rajendran, MBBS
Vivek Bhalla, MD, Stanford University School of Medicine
Dr Carla Nester
Rayan Salih, MD, Northeast Georgia Health System
Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, Mount Sinai Fuster Heart Hospital
AJMC interview with Ali Shan Hafeez and Dr Abdul Rafae Faisal | Background image credit: ipopba - stock.adobe.com
Varsha Tanguturi, MD, MPH, Mass General Hospital
 Khush Kharidia, MD, UT Southwestern
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.